Janani Rangaswami (Washington, USA)

Janani Rangaswami (Washington, USA)

(MD, FACP, FAHA)
Dr. Janani Rangaswami is the chief of nephrology at the Washington DC VA Medical Center, and a professor of medicine at the George Washington University School of Medicine. She is a clinician- researcher with expertise in cardiovascular-kidney medicine and implementation science. As part of her leadership roles in this space, she has served as Chair of the Council on the Kidney in Cardiovascular Disease (KCVD) of the American Heart Association (AHA), and Chair of the Science Committee of KCVD. She led the AHA Scientific Statements on Cardio-Renal Syndrome (2019) and the Cardiorenal Benefits with the Newer Antidiabetic Agents in Kidney Disease (2020). She co- chaired the Cardiovascular-Kidney-Metabolic Health (CKMH) scientific advisory group for the American Heart Association which published a presidential advisory, scientific synopsis, and a novel cardiovascular disease risk prediction equation in individuals with CKM syndrome (2023). Dr. Rangaswami has authored numerous high impact publications in cardiovascular-kidney medicine and is the lead editor of two textbooks in this field: Textbook of Cardio-nephrology and the Textbook of Kidney Disease in the Cardiac Catheterization Laboratory. She has won several awards for teaching and leadership in her career. She is a frequent speaker in cardiology, nephrology, and endocrinology conferences globally.